Lakefront Biotherapeutics | GLPG - ДОЛГ





ДОЛГ Изменить Дата
argenx SE USD 47.16M 4.01M 2025-12
AstraZeneca USD 32.24B 1.68B 2026-06
Biogen USD 8.09B 1.53B 2026-06
Genmab DKK 5.35B 5.2B 2026-03
Gilead Sciences USD 22.17B 2.76B 2026-03
GlaxoSmithKline GBP 19.06B 1.34B 2026-03
GRIFOLS EUR 8.52B 1.15B 2026-06
Hikma Pharmaceutical USD 1.6B 46M 2025-12
Incyte USD 38.27M 1.16M 2026-06
Merck EUR 12.04B 86M 2026-03
Neurocrine Biosciences USD 406.2M 9.1M 2026-03
Novartis USD 49.01B 2.02B 2026-06
Roche Holding CHF 33.03B 1.41B 2025-06
Sanofi EUR 23.58B 3.56B 2026-06
UCB EUR 3.03B 12M 2024-12
Vertex Pharmaceuticals USD 1.98B 8.9M 2026-06